Immunogen reported $-26827000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -62.63M 0.05M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Amgen AMGN:US $ 3188M 218M
Arena Pharmaceuticals ARNA:US $ -143.42M 12.4M
Astellas Pharma 4503:JP Y 53942M 59543M
AstraZeneca AZN:LN 2149M 322M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Bristol Myers Squibb BMY:US $ 5679M 455M
Cerulean Pharma CERU:US $ -9.16M 1.47M
Dicerna Pharmaceuticals DRNA:US $ -38.58M 10.29M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Emergent Biosolutions EBS:US $ 47.7M 76.4M
Exelixis EXEL:US $ 126.68M 128.06M
Halozyme Therapeutics HALO:US $ 93.85M 42.37M
Heron Therapeutics HRTX:US $ -59.74M 8.36M
Immunogen IMGN:US $ -26.83M 1.54M
Karyopharm Therapeutics KPTI:US $ -48819000 3.32M
Macrogenics MGNX:US $ -37498000 11.07M
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Novartis NVS:US $ 4772M 423M
Pfizer PFE:US $ 7593M 610M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Seattle Genetics SGEN:US $ -73.78M 33.35M